OPGEN INC (OPGN) Stock Price, Quote, News and Overview
NASDAQ:OPGN - Nasdaq - US68373L5057 - Common Stock - Currency: USD
OPGN Quote, Performance and Key Statistics
1.96
-0.34 (-14.78%)
The current stock price of OPGN is 1.96 USD. In the past month the price decreased by -34.88%. In the past year, price increased by 14.62%.
OPGN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About OPGN
Company Profile
OpGen Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Rockville, Maryland. The company went IPO on 2015-05-05. OpGen, Inc. is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The firm distributes molecular microbiology solutions that help guide clinicians with more information about life threatening infections to improve patient outcomes and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The firm's product portfolio includes Unyvero Lower Respiratory Tract Panels, Unyvero Urinary Tract Infection Panel, Unyvero System, and Unyvero Resources. The Unyvero LRT panels enable comprehensive detection of the most clinically relevant pathogens and antibiotic resistance markers. The Unyvero Urinary Tract Infection (UTI) panel simultaneously identifies a comprehensive range of pathogens and antibiotic resistance markers associated with urinary tract infections. The Unyvero system uses multiplex PCR technology to simultaneously test for a range of microorganisms and antibiotic resistance markers.
Company Info
OPGEN INC
9717 Key West Avenue, Suite 100
Rockville MARYLAND 20878 US
CEO: Oliver Schacht
Employees: 100
Company Website: https://opgen.com/
Phone: 13018699683
OPGEN INC / OPGN FAQ
What is the stock price of OPGEN INC today?
The current stock price of OPGN is 1.96 USD. The price decreased by -14.78% in the last trading session.
What is the ticker symbol for OPGEN INC stock?
The exchange symbol of OPGEN INC is OPGN and it is listed on the Nasdaq exchange.
On which exchange is OPGN stock listed?
OPGN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for OPGEN INC stock?
6 analysts have analysed OPGN and the average price target is 3.06 USD. This implies a price increase of 56.12% is expected in the next year compared to the current price of 1.96. Check the OPGEN INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is OPGEN INC worth?
OPGEN INC (OPGN) has a market capitalization of 2.65M USD. This makes OPGN a Nano Cap stock.
How many employees does OPGEN INC have?
OPGEN INC (OPGN) currently has 100 employees.
What are the support and resistance levels for OPGEN INC (OPGN) stock?
OPGEN INC (OPGN) has a resistance level at 2.91. Check the full technical report for a detailed analysis of OPGN support and resistance levels.
Is OPGEN INC (OPGN) expected to grow?
The Revenue of OPGEN INC (OPGN) is expected to decline by -0.26% in the next year. Check the estimates tab for more information on the OPGN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy OPGEN INC (OPGN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OPGN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OPGN, evaluating the profitability, health, valuation and growth aspects
- OPGEN INC (OPGN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- OPGEN INC (OPGN) Sales and EPS estimates to see what analysts future expectations are.
- OPGEN INC (OPGN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- OPGEN INC (OPGN) Insider and Institutional Ownership to learn about the owners and their transactions.
- OPGEN INC (OPGN) Stock Chart to make your own analysis
- OPGEN INC (OPGN) Latest news and press-releases to stay up to date.
Does OPGEN INC (OPGN) stock pay dividends?
OPGN does not pay a dividend.
When does OPGEN INC (OPGN) report earnings?
OPGEN INC (OPGN) will report earnings on 2024-11-12, after the market close.
What is the Price/Earnings (PE) ratio of OPGEN INC (OPGN)?
OPGEN INC (OPGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-28.18).
What is the Short Interest ratio of OPGEN INC (OPGN) stock?
The outstanding short interest for OPGEN INC (OPGN) is 0.3% of its float. Check the ownership tab for more information on the OPGN short interest.
OPGN Technical Analysis
OPGN Financial Highlights
Over the last trailing twelve months OPGN reported a non-GAAP Earnings per Share(EPS) of -28.18. The EPS increased by 79.19% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -897.5% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
OPGN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to OPGN. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 99.72% and a revenue growth -0.26% for OPGN